Sami-Sabinsa Group
Sami-Sabinsa Group is a Bangalore-headquartered, family-controlled manufacturer of standardized herbal extracts, nutraceuticals, cosmeceuticals, and specialty chemicals for the pharmaceutical, food, and personal care industries, serving global manufacturers across 19 countries via 14 wholly-owned subsidiaries and a 500+ patent portfolio.
- Company typePrivate
- Founded1991
- HeadquartersBangalore, India
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sami-Sabinsa Group does
Sami-Sabinsa Group Limited is a Bangalore-headquartered, family-controlled manufacturer of standardized botanical extracts, nutraceuticals, cosmeceuticals, probiotics, enzymes, and specialty fine chemicals serving nutraceutical, pharmaceutical, cosmetic, and food & beverage manufacturers globally. The company's portfolio centers on patented, clinically documented branded ingredients—most prominently Curcumin C3 Complex (263+ publications, 109 clinical studies), BioPerine (95% piperine, 63 bioavailability studies), LactoSpore (GRAS-affirmed Heyndrickxia coagulans MTCC 5856), ForsLean, Gugulipid, Selenium SeLECT, Sabroxy, and Cosmoperine—protected by 500+ granted patents and 300+ pending applications across major jurisdictions. Sami-Sabinsa holds 100+ national and international awards including the 2024 Ellis Island Medal of Honor and the 2023 Varro E. Tyler Award from the American Botanical Council, reflecting its industry standing.
Operationally, Sami-Sabinsa runs eight cGMP-certified manufacturing facilities (seven in Karnataka and Telangana, India; one in Payson, Utah) and a 40,000-acre contract farming program across India, Southeast Asia, and Africa involving 5,000+ farmers under buyback agreements. Core technology platforms include Super Critical Fluid (CO2) Extraction at the Nelamangala Bengaluru facility, a continuous stainless-steel-316 extraction line at Dobaspet rated at 40+ tonnes/day of herbal raw material, and nine in-house R&D divisions (Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, Formulation R&D) staffed by 120+ scientists. Certifications across ISO 22000, FSSC 22000, NSF GMP, USP GMP, FAMI-QS, Non-GMO Project, FSSAI, FSRN, and Halal/Kosher enable cross-jurisdictional regulatory access.
The company monetizes through a direct B2B sales model via 14 wholly-owned subsidiaries across 19 countries (USA, India, Australia, Brazil, Canada, China, Germany, Japan, Poland, South Africa, South Korea, UAE, Vietnam) with quote-based pricing and multi-year manufacturer contracts. Revenue streams include ingredient sales (nutraceutical and cosmeceutical), patent licensing of branded ingredients, cGMP contract manufacturing in India and the USA, and contract research services. The group was founded in 1991 by the late Dr. Muhammed Majeed (with Sabinsa Corporation founded in the USA in 1988) and is now led by Dr. Anju Majeed (Group Executive Chairperson) and Shaheen Majeed (Global CEO & MD), with ownership and control remaining within the Majeed family. The group rebranded from Sami Labs Limited to Sami-Sabinsa Group Limited in 2025 and acquired Nature's Formulary on 2025-02-04.
Sami-Sabinsa Group firmographics
Firmographics- Name
- Sami-Sabinsa Group
- Legal name
- Sami-Sabinsa Group Limited
- Website
- https://sami-sabinsagroup.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Sami-Sabinsa Group is a Bangalore-headquartered, family-controlled manufacturer of standardized herbal extracts, nutraceuticals, cosmeceuticals, and specialty chemicals for the pharmaceutical, food, and personal care industries, serving global manufacturers across 19 countries via 14 wholly-owned subsidiaries and a 500+ patent portfolio.
- Ownership category
- akta.pro rank
Sami-Sabinsa Group industry classification
Industry- Product category
- Nutraceutical and Cosmeceutical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK)
- akta.pro secondary industry
- Probiotics & Digestive Health Supplements (CRADAGAF)
Keywords
Where Sami-Sabinsa Group is headquartered
LocationHeadquarters
- HQ city
- Bangalore
- HQ country
- India
- HQ region
- Asia
Offices16 records
Markets served
Sami-Sabinsa Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Nutraceutical Ingredients: Sale of standardized phyto extracts, enzymes, probiotics, prebiotics, postbiotics, minerals, and nutritional fine chemicals to dietary supplement manufacturers
- Cosmeceutical Ingredients: Supply of natural actives, peptides, anti-glycation ingredients, dermaceuticals, and nutricosmetics to personal care and cosmetics manufacturers
- Patent Licensing: Licensing of patented products and proprietary formulations including Curcumin C3 Complex, BioPerine, LactoSpore, ForsLean, and other branded ingredients
- Contract Manufacturing: Custom manufacturing services at cGMP certified facilities in India and USA for nutraceutical and pharmaceutical ingredients
- Contract Research Services: R&D services including synthesis, phytochemistry, biotechnology research, tissue culture, and analytical method development for external clients
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B bulk ingredient supply with custom formulation capabilities |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Sami-Sabinsa Group product offering
Product offeringCore offering
Sami-Sabinsa Group manufactures and markets standardized herbal extracts, nutraceutical and cosmeceutical ingredients (including Curcumin C3 Complex, BioPerine, LactoSpore, ForsLean, Boswellin), probiotics, postbiotics, enzymes, multi-enzyme blends, minerals, peptides, and specialty fine chemicals. It sells these patented, clinically validated ingredients to dietary supplement, pharmaceutical, food and beverage, and personal care manufacturers through its own direct sales network across 19 countries.
Product overview
Sami-Sabinsa Group is a research-focused multinational health science company that manufactures and markets a comprehensive portfolio of patented nutraceutical and cosmeceutical ingredients. The company's product ecosystem centers on its core offerings: Standardized Phyto Extracts (featuring flagship brands like Curcumin C3 Complex®, BioPerine®, ForsLean®, Boswellin®, Gugulipid®, and Shagandha™), complemented by Super Critical Fluid (SCF) Extracts using eco-friendly CO2 extraction technology, and a complete biotics portfolio including LactoSpore®, ImmunoSpore™, LactoWise®, and LactoCran® under the Prebiotics, Probiotics, Postbiotics & Synbiotics category. The company also offers Phyto Functional Blends (LeanGard®, HotSip®, LivLonga®, Metabolicgard®, NiLitis® SR, Selendrovir™, WithanAlpha™) that combine multiple patented ingredients for targeted health benefits, and the Geroceuticals™ line for healthy aging. Supporting these core products are Cosmeceutical Ingredients including Natural Actives, Peptides (Olepent®, Oletrip®), Anti-glycation, Dermaceuticals, Nutricosmetics, and Specialty Chemicals. The portfolio spans over 120 products across 8 manufacturing units, supported by Contract Farming services for sustainable raw material sourcing and Contract Research capabilities for custom development. Notable branded products include: Curcumin C3 Complex® (95% Curcuminoids, 263+ publications), BioPerine® (95% Piperine, bioavailability enhancer), LactoSpore® (spore-forming probiotic), Selenium SeLECT® (L-Selenomethionine), Boswellin® (Boswellia serrata extracts), ForsLean® (Coleus forskohlii, 10-40% Forskolin), Gugulipid® (Commiphora mukul), Shagandha™ (Ashwagandha), Saberry® (Amla/Emblica), Cococin® (Coconut), Silbinol® (Pterocarpus), and SabiWhite® (Tetrahydrocurcumin).
Differentiator
Problem solved
Functional benefit
Brands
- Curcumin C3 Complex: Patented composition of curcuminoids from turmeric rhizomes, extensively studied with 263+ publications including 109 clinical studies
- BioPerine
- LactoSpore
- Gugulipid
- Boswellin
- ForsLean
- Saberry
- Silbinol
- Selenium SeLECT
- Resvenox
- Centellin
- Nigellin
- Shagandha
- DigeZyme
- Geroceuticals
Products and services
- Standardized Phyto Extracts A comprehensive range of standardized herbal extracts including Curcumin C3 Complex®, BioPerine®, ForsLean®, Boswellin®, Gugulipid®, Shagandha™ and other botanical ingredients with standardized active compound concentrations for nutraceutical and pharmaceutical manufacturers.
- Super Critical Fluid (SCF) Extracts Eco-friendly CO2-based botanical extracts including Nigellin® Black Cumin extracts, Ginger SCF Extract, Turmeric SCF Extract, and Guggul SCF Extract (Gugulipid®) with intact bio-potency for nutraceutical manufacturers.
- Phytochemicals for Nutritional Use Pure phytochemical compounds including Calebin A (CurCousin™), Resveratrol (Resvenox®), Oxyresveratrol (OxyResvenox®), Forskolin Carbonate, Diindolylmethane (DIM), and Indole-3-Carbinol for functional nutrition applications.
- Specialty Chemicals - Nutraceuticals Specialty fine chemicals including Eflornithine Hydrochloride, chiral drug intermediates, and custom synthesis for nutritional and pharmaceutical applications.
- Nutritional Fine Chemicals Fine chemicals for nutritional applications including amino acid derivatives, specialized intermediates, and research chemicals.
- Multi-enzyme Blends DigeZyme® and DigeZyme® EC enzyme blends combining α-Amylase, Cellulase, Lactase, Lipase, and Neutral protease for digestive health supplement manufacturers.
- Prebiotics, Probiotics, Postbiotics & Synbiotics Complete biotics portfolio including LactoSpore® (Heyndrickxia coagulans MTCC 5856), ImmunoSpore™, LactoWise®, LactoCran®, FenuFibers®, Fenumannan®, and Starmeric® for gut health and microbiome support.
- Minerals for Nutritional Use Bioavailable mineral compounds including Selenium SeLECT®, MethySelene®, SelenoForce®, Zinc Citrate, Zinc Monomethionine, Magnesium compounds, and Vanadium forms.
- GRAS Affirmed Products Products with FDA Generally Recognized As Safe status including BioPerine®, Curcumin C3 Complex®, Citrin K®, Cococin™, LactoSpore®, Saberry®, Selenium SeLECT®, CurCousin™, and Curcumin C3 Reduct®.
- Geroceuticals™ Healthy aging ingredient line including Shagandha™ (Ashwagandha), Nigellin® Black Cumin extracts, Bacopin® (Brahmi), Silbinol® (Pterocarpus), Sabroxy® (Oroxylum), Centellin® (Gotu Kola), and Tinofolin® (Guduchi) for longevity and cognitive health.
- Phyto Functional Blends Proprietary combination products including LeanGard®, HotSip®, LivLonga®, Metabolicgard®, NiLitis® SR, OmegaMax, Selendrovir™, WithanAlpha™, and ZeaLutein® for targeted health benefits.
- Natural Actives Cosmeceutical natural active ingredients including Saberry® (Amla), Boswellin® CG (Boswellia), Bacopin® (Brahmi), Centellin® CG (Gotu Kola), Venocin® (Horse Chestnut), Silbinol® (Pterocarpus), SabiWhite® (Tetrahydrocurcumin), and Cosmoperine® (Tetrahydropiperine).
- Peptides Bioactive peptides including Olepent® (Oleanoyl sh-Pentapeptide-4), Oletrip® (Oleanoyl tripeptide), and PeptiSeLect® (Methylseleno Carboxypropylglutamine) for skin care and anti-aging applications.
- Contract Farming Service Sustainable sourcing service through contract cultivation of medicinal plants across 40,000+ acres in India, Southeast Asia, and Africa, supporting Good Agricultural Practices and ensuring raw material quality supply for the group's manufacturing operations.
- Contract Research Service Comprehensive R&D services including synthesis of organic molecules, chiral synthesis, SCFE, biotechnology research, phytochemistry, tissue culture, biochemical analysis, cosmetic claim substantiation, and pilot plant scale-up, offered in collaboration with IISc, IIT-Mumbai, IICT-Hyderabad, and UICT-Mumbai.
Quantifiable outcome
- 500+ US and International patents awarded
- +4 more outcomes
Companies that use Sami-Sabinsa Group
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Sami-Sabinsa Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Sami-Sabinsa Group partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered flagship, major, core and strategic.
- The Hindu GroupflagshipSami-Sabinsa Group served as Presenting Partner for The Hindu Huddle on Campus event at Amity University Bengaluru and the main two-day The Hindu Huddle conclave. The partnership supports youth engagement platform focusing on contemporary issues and provides visibility for the company's brand in India.
- Kerry Inc.majorSami-Sabinsa Group and Kerry Inc. jointly challenged FSSAI advisory restricting use of Ashwagandha leaves in dietary supplements, filing petitions at Karnataka High Court. Both companies sought to quash the advisory that prohibited use of leaves and leaf extracts, arguing it required formal regulation amendment. The court granted interim relief staying the ban for both petitioners.
- The Hindu GroupflagshipPresenting Partner for The Hindu Huddle conference themed 'A World in Transition' bringing together ministers, ambassadors, MPs, and artists for discussions on geopolitics, AI, and democracy.
- Indian FarmerscoreContract farming partnerships with thousands of farmers across India, particularly in Tamil Nadu, Karnataka, and other states. Farmers receive planting supplies, training, buyback agreements, and guaranteed prices for cultivating medicinal plants. The model extends to Southeast Asian countries and Africa.
- Princeton UniversitystrategicSabinsa Corporation is an Industrial Associate Program (IAP) member of Princeton University, enabling access to sophisticated instruments including X-ray crystallography for research purposes.
- IIT MumbaistrategicCollaborative research partnerships with Indian Institute of Technology Mumbai for process and method development.
- IICT HyderabadstrategicCollaborative research with Indian Institute of Chemical Technology for key process development.
- IISc BangalorestrategicCollaborative research with Indian Institute of Science for advanced analytical capabilities and research support.
- UICT MumbaistrategicAcademic collaboration for research and development in pharmaceutical technology.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Sami-Sabinsa Group competitors and assessment
Company assessmentDirect peers
- Indena S.p.A. Italian-based global leader in standardized botanical extracts and active pharmaceutical ingredients derived from plants. Directly comparable B2B ingredient manufacturer with a similar scientific, patented ingredient, and contract farming/procurement model.
- OmniActive Health Technologies: Mumbai-headquartered supplier of carotenoids, botanical extracts, and specialty nutraceutical ingredients. Closest Indian peer with overlapping product categories (vision health, cognition, immunity) and similar branded-ingredient go-to-market model.
- Martin Bauer Group: Germany-based global supplier of botanical extracts, tea, and plant-based ingredients for the food, beverage, nutraceutical, and pharmaceutical industries. Directly comparable in scale, scientific approach, and vertically integrated raw material sourcing.
- Bio-Botanica: US-based manufacturer of botanical extracts serving the cosmetic, personal care, and nutraceutical markets. Comparable in standardized herbal extract offering and B2B ingredient distribution model, though smaller in scale.
- Layn Natural Ingredients: China/US-based producer of high-purity botanical extracts and natural sweeteners (including stevia, monk fruit, and polyphenols) for nutrition and food applications. Directly comparable in standardized polyphenol extract manufacturing and global ingredient distribution.
Broad incumbents
- Naturex (Givaudan): Now part of Givaudan, Naturex is a broad-based natural ingredients supplier across food, beverage, nutrition, and personal care. Broader portfolio than Sami-Sabinsa but overlapping in standardized plant extracts and nutraceutical actives.
- Kemin Industries: Privately held US ingredient manufacturer serving animal nutrition, human nutrition, and personal care with proprietary molecules. Comparable in scientific differentiation and proprietary ingredient focus, though broader in end-market coverage.
- Kerry Group: Ireland-headquartered global taste and nutrition company with a substantial nutraceutical ingredients business. Already a Sami-Sabinsa legal co-petitioner (Ashwagandha FSSAI case) and an overlapping competitor in functional food and supplement ingredients.
Emerging players
- Hunan Sunfull Bio-tech: China-based producer of standardized botanical extracts (green tea, grape seed, ginseng, etc.) for nutraceutical and functional food markets. Overlaps in standardized extract technology and global B2B distribution, though at a smaller scale.
- Cepham (Cepham Life Sciences): US-based supplier of standardized botanical and herbal extracts to the dietary supplement industry with vertically integrated sourcing in India and Southeast Asia. Comparable in contract farming integration and B2B ingredient distribution model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Sami-Sabinsa Group social profiles
Digital presenceSami-Sabinsa Group compliance and trust
Trust signalCompliance14 records
Sami-Sabinsa Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sami-Sabinsa Group leadership team
Management profileNumber of profiles
Profiles5 records
Sami-Sabinsa Group subsidiaries and ownership
Company hierarchySubsidiaries13 records
Sami-Sabinsa Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sami-Sabinsa Group M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sami-Sabinsa Group
What does Sami-Sabinsa Group do?
Sami-Sabinsa Group manufactures and markets standardized herbal extracts, nutraceutical and cosmeceutical ingredients (including Curcumin C3 Complex, BioPerine, LactoSpore, ForsLean, Boswellin), probiotics, postbiotics, enzymes, multi-enzyme blends, minerals, peptides, and specialty fine chemicals. It sells these patented, clinically validated ingredients to dietary supplement, pharmaceutical, food and beverage, and personal care manufacturers through its own direct sales network across 19 countries.
Is Sami-Sabinsa Group a public or private company?
Sami-Sabinsa Group is a private company. It is classified as family owned and is currently operating.
When was Sami-Sabinsa Group founded?
Sami-Sabinsa Group was founded in 1991. It employs 501 to 1,000 people.
Where is Sami-Sabinsa Group based?
Sami-Sabinsa Group is headquartered in Bangalore, India, in the Asia region.
How does Sami-Sabinsa Group make money?
Five revenue lines are on record. Nutraceutical Ingredients are the primary driver. The others are cosmeceutical Ingredients, patent Licensing, contract Manufacturing and contract Research Services.
Who are Sami-Sabinsa Group's main competitors?
Direct peers on record are Indena S.p.A., OmniActive Health Technologies, Martin Bauer Group, Bio-Botanica and Layn Natural Ingredients. Broad incumbents are Naturex (Givaudan), Kemin Industries and Kerry Group. Emerging players are Hunan Sunfull Bio-tech and Cepham (Cepham Life Sciences).
Does Sami-Sabinsa Group have an API?
No public API is recorded for Sami-Sabinsa Group.
What industry is Sami-Sabinsa Group in?
Sami-Sabinsa Group's product category is Nutraceutical and Cosmeceutical Ingredients. Its primary akta.pro industry code is AFAJAKAK, Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin), with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325411 and its SIC code is 2833.